DIFFERENTIAL EXPRESSION OF THE MYOCYTE ENHANCER FACTOR-2 FAMILY OF TRANSCRIPTION FACTORS IN DEVELOPMENT - THE CARDIAC FACTOR BBF-1 IS AN EARLY MARKER FOR CARDIOGENESIS
S. Goswami et al., DIFFERENTIAL EXPRESSION OF THE MYOCYTE ENHANCER FACTOR-2 FAMILY OF TRANSCRIPTION FACTORS IN DEVELOPMENT - THE CARDIAC FACTOR BBF-1 IS AN EARLY MARKER FOR CARDIOGENESIS, Molecular and cellular biology, 14(8), 1994, pp. 5130-5138
In the present study, we have used single chicken blastoderms of defin
ed early developmental stages, beginning with the prestreak stage, sta
ge 1 (V. Hamburger and H. L. Hamilton, J. Morphol. 88:49-92, 1951), to
analyze the onset of cardiac myogenesis by monitoring the appearance
of selected cardiac muscle tissue-specific gene transcripts and the fu
nctional expression of the myocyte enhancer factor 2 (MEF-2) proteins.
Using gene-specific oligonucleotide primers in reverse transcriptase
PCR assay, we have demonstrated that the cardiac myosin light-chain 2
(MLC2) and alpha-actin gene transcripts appear as early as stage 5, i.
e., immediately after the cardiogenic fate assignment at stage 4. Cons
istent with this observation is the developmental expression pattern o
f DNA-binding activity of BBF-1, a cardiac muscle-specific member of t
he MEF-2 protein family, which also begins at stage 5 prior to MEF-2.
Differential expression of DNA-binding complexes is also observed,vith
another AT-rich DNA sequence (CArG box) as probe, but the binding pat
tern with the ubiquitous TATA-binding proteins remains unchanged durin
g the same developmental period. Thus, the cardiogenic commitment and
differentiation of the precardiac mesoderm, as exemplified by the appe
arance of cardiac MEF-2, MLC2, and alpha-actin gene products, occur ea
rlier than previously thought and appear to be closely linked. The ons
et of skeletal myogenic program follows that of the cardiogenic progra
m with the appearance of skeletal MLC2 at stage 8. We also observed th
at mRNA for the MEF-2 family of proteins appears as early as stage 2 a
nd that for CMD-1, the chicken counterpart of MyoD, appears at stage 5
. The temporal separation of activation of cardiac and skeletal MLC2 g
enes, which appears immediately after the respective fate assignments,
and those of cardiac MEF-2 and CMD-1, which occur before, are consist
ent with the established appearance of the myogenic programs and with
the acquisition pattern of the two tissue-specific morphological chara
cteristics in the early embryo. The preferential appearance of BBF-1 a
ctivity in precardiac mesoderm, relative to that of MEF-2, indicates t
hat these two protein factors are distinct members of the MEF-2 family
and provides a compelling argument in support of the potential role o
f BBF-1 as a regulator of the cardiogenic cell lineage determination,
while cardiac MEF-2 might be involved in maintenance of the cardiac di
fferentiative state.